Home / Generics

Generics

News

Australia approves first capsule-form Viagra generic posted 14/09/2018

Singapore-based iX Biopharma announced on 6 August 2018 that it had received approval from Australia’s Therapeutic Goods Admi...

Generic diabetes and cancer drugs pose challenge to Bristol-Myers Squibb and Eli Lilly posted 07/09/2018

Generics manufacturers in Bangladesh and Germany have recently announced the launch of generic versions of Bristol-Myers Squi...

Ulcerative colitis and diabetes generics launched in US posted 31/08/2018

Israeli generics giant Teva Pharmaceutical Industries (Teva) announced on 9 July 2018 that it had launched generic budesonide...

Generic cancer pain relief launched in Japan posted 20/07/2018

Japan-based Daiichi Sankyo announced on 15 June 2018 that it had launched a generic version of cancer pain relief Fentos Tape...

FDA approves first Suboxone generics for opioid dependence posted 13/07/2018

The US Food and Drug Administration (FDA) announced on 14 June 2018 that it had approved the first generics of Suboxone (bupr...

 

Research

Factors influencing the use of trade and generic names posted 21/09/2018

Using trade names for drugs in clinical practice has been shown to increase the use of brand-name drugs. Despite efforts by a...

Hospital use of generic drugs increases adoption by community pharmacies posted 14/09/2018

A recent Japanese study reveals that hospital adoption of generic drugs can also promote their use by community pharmacies. T...

Product recalls increase with increasing generics competition posted 24/08/2018

Generics price competition may lead to relaxed manufacturing standards and ultimately lower quality products, according to a...

Patient sociodemographics and use of generics posted 20/07/2018

Researchers from the US have found that poorer patients are more likely to use generics [1].

Generic sofosbuvir and daclatasvir bioequivalent to originators posted 13/07/2018

With the aim of eliminating hepatitis C (HCV) by 2030, some originator pharmaceutical companies have granted voluntary licenc...

 

General

Novartis divests dermatology and generic oral solids portfolios and part ways with Alcon posted 21/09/2018

Swiss drugmaker Novartis is to divest the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo an...

Novartis accused of pay-for-delay, while Amgen sues over generic thyroid drug posted 14/09/2018

Novartis are facing a lawsuit for attempts to prevent generic versions of their hypertension treatment Exforge, and Amgen ann...

FDA significantly increases generic user fees in 2019 posted 11/09/2018

The US Food and Drug Administration (FDA) has increased the amount that generics manufacturers will have to pay for large-siz...

Generics applications under review by EMA – June 2018 posted 28/08/2018

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...

MSF challenges hepatitis C patent in China posted 28/08/2018

Médecins Sans Frontières (MSF, Doctors Without Borders) announced on 19 June 2018 that it was challenging the ‘unmerited’ pat...